Pain Flare After Steroid Injections, Radiofrequency Ablation and Botox: Causes, Recovery Timelines, Post-Neurotomy Neuritis & Expert Management Guide

Introduction

Post-procedural pain flare-up is one of the most clinically important and commonly misunderstood issues in interventional pain medicine. Many patients expect immediate relief after an injection or radiofrequency treatment, so a temporary worsening of pain can be alarming and may be wrongly interpreted as treatment failure or procedural complication. In reality, a short-term increase in pain is a recognised response after several commonly performed interventions, including corticosteroid injections, radiofrequency ablation (RFA), and botulinum toxin (Botox) therapy.

Pain flare reactions matter for several reasons. They influence patient confidence, satisfaction, and willingness to continue with treatment plans. They can also lead to unnecessary anxiety, unplanned medical reviews, inappropriate antibiotic use, or the mistaken belief that a successful procedure has “made things worse.” For clinicians, understanding the expected pattern of post-procedural discomfort is essential in distinguishing a normal inflammatory response from complications such as infection, nerve irritation, structural injury, or failure of the underlying treatment target.

The mechanisms of pain flare vary depending on the procedure performed. After corticosteroid injections, the reaction is commonly linked to a transient crystal-induced inflammatory response. Following radiofrequency treatment, discomfort is more often related to controlled thermal tissue injury, local inflammation, and in some cases temporary neuritic pain during nerve healing. After Botox injections, soreness may arise from needle trauma, temporary muscle irritation, or delayed onset of therapeutic effect. Each mechanism has different timelines, clinical features, and management strategies.

This comprehensive review examines the causes, incidence, duration, assessment, and treatment of pain flare-up following the principal procedures used in modern pain practice. The article is structured to guide both clinicians and patients from basic mechanisms through to practical decision-making, helping set realistic expectations while highlighting when symptoms require further medical attention.

Pain Flare After Corticosteroid Injections

Corticosteroid injections are widely used in pain medicine because they can reduce inflammation and improve pain arising from joints, bursae, tendons, muscles, and irritated nerves. However, a proportion of patients experience a temporary worsening of pain before improvement begins. This is commonly referred to as a post-injection steroid flare.

A steroid flare is usually a short-lived inflammatory reaction rather than a sign that the procedure has failed. It may present with increased pain, soreness, stiffness, swelling, warmth, redness, or tenderness around the injection site. Overall, post-injection pain flare has been reported in approximately 20% of patients, although published rates vary from around 3% to 25%, depending on the injection site, steroid preparation used, and how flare is defined.

Why Do Steroid Injections Worsen Pain Before They Help?

Many injectable corticosteroids are supplied as particulate suspensions. This means the steroid is not completely dissolved as a clear solution. Instead, it contains microscopic crystals designed to remain in the tissues and provide a longer-lasting anti-inflammatory effect.

This prolonged tissue presence is one reason steroid injections can continue working after the local anaesthetic has worn off. However, the same crystalline structure can also trigger a temporary inflammatory response. The body may recognise the crystals as foreign particles, and immune cells attempt to clear them. This can briefly increase local inflammation before the steroid’s therapeutic anti-inflammatory effect becomes dominant.

This explains the clinical paradox: the medication is anti-inflammatory, but the crystalline depot used to deliver it can temporarily irritate tissue.

The Crystalline-Induced Inflammatory Reaction

The crystalline-induced inflammatory reaction is one of the most important mechanisms behind steroid flare.

After injection, corticosteroid crystals can be engulfed by immune cells such as macrophages. Once these crystals are internalised, they may destabilise lysosomes inside the immune cell. This can release enzymes and activate inflammatory pathways, including the NLRP3 inflammasome pathway.

The result is release of inflammatory cytokines, including interleukin-1 related mediators, which can produce local pain, swelling, warmth, stiffness, and increased sensitivity.

Step	What happens	Clinical effect
Steroid crystals are deposited	Particulate steroid remains in the tissue	Longer duration of action
Immune cells recognise crystals	Macrophages attempt to clear them	Local inflammatory activation
Lysosomal irritation occurs	Inflammatory pathways are triggered	Pain, soreness, swelling
Cytokines are released	Local nerves become sensitised	Temporary worsening of pain
Steroid effect becomes dominant	Inflammation is suppressed	Pain begins to improve

This reaction is usually self-limiting. In most patients, the flare settles as the initial crystal-related irritation reduces and the anti-inflammatory action of the steroid becomes more clinically apparent.

The Corticosteroid Paradox

Corticosteroids are powerful anti-inflammatory medicines, but their particulate form can briefly behave like an irritant. The steroid molecule is intended to reduce inflammation, but the physical crystal can provoke inflammation while it is being dispersed and cleared.

This is why a patient may feel worse for a short period after treatment, then improve over the following days. It does not necessarily mean that the injection has caused damage or that the target was wrong.

Does the Type of Steroid Matter?

Yes. The type of corticosteroid can influence flare risk because different steroids vary in solubility, particle size, crystal persistence, and tendency to aggregate.

Some steroids are non-particulate and behave more like true solutions. Others are particulate suspensions designed to stay longer at the injection site. The more persistent the crystal depot, the greater the theoretical potential for local crystal-related irritation.

Steroid preparation	Particle behaviour	Potential relevance to flare
Dexamethasone sodium phosphate	Non-particulate solution; very small particles; does not significantly aggregate	Lower risk of crystal flare, but often shorter tissue persistence
Betamethasone sodium phosphate / acetate	Combination of soluble and particulate components	Faster onset from soluble component, depot effect from particulate component
Triamcinolone acetonide	Particulate crystalline suspension; poorly soluble	Longer duration of action; flare possible but some studies report lower flare rates than methylprednisolone
Methylprednisolone acetate	Particulate suspension; densely packed particles; may aggregate with dilution	Higher flare risk reported in some comparative studies
Triamcinolone hexacetonide	Very low solubility; prolonged tissue persistence	Longer depot effect, but potential for prolonged crystal presence

A direct comparison in shoulder injections found flare reactions in 22.8% of patients receiving methylprednisolone acetate compared with 4.0% receiving triamcinolone acetonide. This suggests that steroid choice can meaningfully influence flare risk, although clinical decisions must also consider the target tissue, safety profile, desired duration of action, and whether particulate steroid is appropriate for the injection site.

Why Crystal Properties Matter

Crystal behaviour can influence flare in several ways. Larger or more persistent crystals may remain visible in tissues for longer and may produce a stronger local immune response. Crystals can also interact with cell membranes, disturb membrane integrity, and be engulfed by synovial or immune cells. Larger, denser, or more persistent crystals may therefore create a more intense or longer-lasting inflammatory signal.

Crystal factor	Why it matters
Particle size	Larger particles may be more irritating and harder to clear
Solubility	Less soluble steroids persist longer in tissues
Aggregation	Clumping may increase local concentration and inflammatory response
Tissue persistence	Longer crystal presence may prolong irritation in susceptible patients
Injection site	Confined spaces may concentrate crystals more than large joints

This is clinically relevant because the same steroid preparation may behave differently in a large joint, a tendon sheath, a muscle, or around a nerve.

Does Mixing Steroid With Local Anaesthetic Influence Flare?

Many steroid injections are mixed with local anaesthetic. This may provide immediate short-term pain relief, confirm accurate placement, and improve patient comfort. However, mixing steroid with local anaesthetic can alter crystal behaviour in some preparations.

The main concern is that mixing may change particle size, aggregation, or dispersion. If crystals become larger or more clustered, they may theoretically increase local irritation. This effect appears to vary depending on the steroid preparation and the anaesthetic used.

Mixing factor	Possible effect
Steroid type	Some preparations are more prone to particle aggregation
Local anaesthetic used	Different anaesthetics may interact differently with steroid suspensions
Dilution medium	Saline or anaesthetic may alter particle distribution
Final concentration	More concentrated deposits may irritate confined tissues
Injection site volume	Small spaces may be less able to disperse crystals

This does not mean that mixing steroid with local anaesthetic is wrong. It is common practice and often clinically useful. However, it explains why flare risk may not depend only on the steroid itself, but also on how it is prepared, diluted, and delivered.

Does Injectate Volume or Steroid Concentration Matter?

Injectate volume and concentration may influence flare severity, particularly in confined anatomical spaces.

A larger volume may help disperse the steroid over a wider area in some situations, but in tight spaces it can also produce pressure-related discomfort. A more concentrated steroid deposit may create a higher local crystal load, potentially increasing irritation.

Injection site	Why flare may feel different
Large joints	Synovial fluid may dilute and disperse crystals
Small joints	Less space for dispersion; pressure effect may be greater
Tendon sheaths	Confined space and sensitive soft tissue structures
Around nerves	Small perineural space; irritation may feel sharp or neuropathic
Muscle / trigger points	Needle trauma plus inflammatory trigger point chemistry
Epidural or spinal regions	Nerve root irritation and injectate volume may contribute

Practical Clinical Message

Steroid flare is common, usually temporary, and often settles within a few days. It is caused by a combination of crystal-related inflammation, local tissue irritation, and site-specific factors. The type of steroid, crystal behaviour, mixing with local anaesthetic, injectate volume, tissue confinement, and baseline inflammation may all influence how much flare a patient experiences. The key is careful counselling. Patients should understand that a temporary worsening of pain can occur before improvement begins, but they should also know when symptoms are not typical and require review.

Site-Specific Steroid Flare Reactions

Not all steroid flares feel the same. The same corticosteroid preparation may produce very different post-injection reactions depending on where it is placed. Tissue structure, available space for crystal dispersion, vascularity, nerve density, baseline inflammation, and mechanical sensitivity all influence how a flare presents.

This is clinically important because a patient receiving a shoulder joint injection, a nerve block, or a trigger point injection may all receive steroid, yet the post-procedure experience can be very different.

Joint Injections

Joint injections are among the most common uses of corticosteroids and are frequently performed for osteoarthritis, inflammatory flare-ups, synovitis, adhesive capsulitis, and other painful musculoskeletal conditions.

In many joints, the presence of synovial fluid provides a medium that can help disperse corticosteroid crystals over a wider area. This may reduce highly concentrated crystal deposition at a single focal point compared with tighter soft-tissue spaces.

However, joints can still flare significantly. When flare occurs, patients may notice:

• Increased joint pain or throbbing
• Temporary stiffness
• Swelling or pressure sensation
• Reduced range of motion for several days
• Warmth around the joint

Large joints such as the knee or shoulder may tolerate volume better than smaller joints, but they can still develop pronounced reactive synovitis after injection.

Small joints in the hands or feet may feel more pressure-sensitive because of limited intra-articular space.

Around Nerves (Perineural Injections)

Steroid injections around nerves can feel very different from joint flares because nerves are biologically sensitive structures and the surrounding space is often narrow.

When steroid is placed near a peripheral nerve, temporary flare may arise from several mechanisms:

• Local crystal-related inflammation in a confined perineural space
• Mechanical irritation from needle placement
• Pressure effects from injectate volume
• Temporary sensitisation of an already irritated nerve
• Vasoconstrictive or local tissue effects around the nerve environment

Patients may describe:

• Burning pain
• Electric or shooting discomfort
• Tingling or buzzing sensations
• Temporary increase in familiar nerve pain
• Hypersensitivity for several days

This can be alarming, but it does not automatically mean nerve injury. In many cases it represents transient irritation around an already sensitised nerve.

Because perineural spaces are tighter than joints, even small changes in pressure or inflammation may be felt more intensely.

Muscle and Trigger Point Injections

Steroid injections into muscle or myofascial trigger points may flare for reasons beyond the steroid itself.

Muscle tissue can become sore simply from needle penetration. Studies have shown post-injection soreness can occur even with dry needling or saline, demonstrating that mechanical needle trauma alone can provoke symptoms.

When steroid and local anaesthetic are added, other factors may contribute:

• Local tissue irritation from the injectate
• Temporary muscle fibre injury
• Stretching of a tight trigger point band
• Chemical irritation within an already inflamed trigger point environment
• Local bruising or spasm response

Trigger points often contain elevated inflammatory mediators such as substance P, bradykinin, and cytokines. Introducing steroid crystals into this sensitised environment may briefly worsen symptoms before relaxation and pain reduction occur.

Patients commonly describe:

• Deep aching
• Bruised sensation
• Tightness
• Temporary spasm
• Soreness on movement or stretching

Why Some Areas Flare More Than Others

Several factors explain why one anatomical region may flare more than another:

Factor	Why It Matters
Available space	Tight compartments concentrate crystals and pressure
Nerve density	Highly innervated tissues feel irritation more intensely
Baseline inflammation	Already inflamed tissues may react more strongly
Tissue type	Muscle, tendon, synovium, and nerve tissue respond differently
Injectate volume	Volume may be well tolerated in large joints but not confined spaces
Mechanical sensitivity	Some areas are more sensitive to needling trauma
Movement demand	Constantly moving regions may remain sore longer

For example, a knee joint may feel swollen and stiff, a nerve injection may feel burning or tingling, a trigger point injection may feel bruised and tight, and a small hand joint may feel pressure-sensitive.

Practical Clinical Message

Site-specific flare reactions are common and usually temporary. Understanding the location of the injection helps predict the type of discomfort a patient may feel afterwards. This allows better counselling, reduces anxiety, and helps distinguish expected recovery from true complications.

How Long Does Steroid Flare Usually Last?

The duration of a steroid flare is variable, but in most patients it is short-lived. A typical flare begins within the first few hours after the injection, becomes most noticeable over the first 24–48 hours, and then gradually settles as the local inflammatory reaction reduces and the steroid effect begins to take over.

Most steroid flares resolve within 24 to 72 hours. Some may last a little longer, particularly when injections are performed into more sensitive or confined tissues. In the majority of patients, symptoms should be clearly improving within the first few days.

Typical Timeline

Time after injection	Typical clinical pattern
First few hours	Local soreness or increase in familiar pain may begin
24–48 hours	Flare may be at its most noticeable
48–72 hours	Symptoms usually start to settle
Up to 1 week	Some patients may continue to experience discomfort, especially in sensitive areas
After 1 week	Persistent or worsening pain should be reassessed clinically

For many patients who respond well to corticosteroid injection, pain improvement begins within the first few days. Among patients who ultimately obtain benefit, 60.4% experience pain improvement within 3 days, and more than 93% obtain relief within one week.

This means that the first week after injection is often a transition period. A patient may initially feel worse, then gradually improve as the flare settles and the anti-inflammatory effect becomes more clinically apparent.

When Pain Lasts Longer Than Expected

Pain that lasts longer than the usual flare window does not automatically mean that something serious has occurred. However, it should be interpreted carefully.

A simple steroid flare is usually expected to follow an improving trajectory. The pain may be uncomfortable, but it should gradually settle rather than become progressively worse.

Pain should be reassessed if it:

• Continues to worsen after the first few days
• Persists beyond 72–96 hours without any sign of improvement
• Is associated with increasing redness, warmth, or swelling
• Is accompanied by fever or feeling generally unwell
• Causes new weakness, spreading numbness, or severe functional deterioration
• Feels very different from the expected post-injection soreness

The key clinical issue is not duration alone, but the pattern. Slowly improving pain is more reassuring than pain that is escalating, spreading, or associated with systemic symptoms.

Why Some Patients Flare for Several Weeks Without Infection

A small group of patients report pain flare lasting several weeks after corticosteroid injection, even when there is no infection, no structural injury, and no obvious procedural complication. This is recognised clinically, but the exact mechanism is not well explained in the medical literature.

Several factors may contribute.

Possible factor	How it may contribute
Corticosteroid preparation and crystal persistence	Some steroid preparations are less soluble and remain as crystals for longer. A more persistent crystal depot may prolong local irritation in susceptible patients.
Individual inflammatory response	Patients vary in how strongly their immune system reacts to injected crystals and local tissue irritation. Younger age has been identified as a risk factor for steroid flare in one prospective study.
Tissue trauma from the procedure	Needle passage, local tissue disruption, bleeding, bruising, or irritation of adjacent soft tissues may produce pain that lasts longer than a classic crystal flare.
Baseline tissue sensitivity	Trigger points, tendinopathic tissue, irritated nerves, and chronically inflamed joints may react more strongly to even minor additional irritation.
Confined anatomical spaces	In smaller joints, tendon sheaths, perineural spaces, or tight soft-tissue compartments, the same volume or concentration may create a more intense local reaction.

Practical Clinical Message

Most steroid flares settle within a few days, and many patients who benefit from the injection notice improvement within the first week. A flare lasting several weeks is not typical, but it can occur without infection or major complication. In these cases, the most important clinical question is whether the pain is gradually improving or progressively worsening. A slow but steady improvement is usually reassuring. Progressive pain, fever, increasing swelling, spreading redness, new neurological symptoms, or major functional decline should prompt urgent reassessment.

Distinguishing Steroid Flare from Complications

Most steroid flares are temporary and settle without specific treatment. However, not every increase in pain after an injection should be assumed to be a simple flare. The important clinical task is to distinguish an expected post-injection reaction from complications such as infection, tendon injury, structural damage, or treatment failure.

The distinction depends on four key features:

Clinical feature	Why it matters
Timing	When did the pain start after the injection?
Trajectory	Is the pain improving, stable, or worsening?
Associated symptoms	Are there fever, redness, swelling, weakness, or systemic symptoms?
Pain pattern	Is this the same pain, a new pain, or a focal structural pain?

A simple steroid flare usually begins within hours, is most noticeable in the first 24–48 hours, and then gradually improves. Pain that is progressively worsening, spreading, associated with systemic symptoms, or very different from the expected post-injection soreness needs reassessment.

Steroid Flare vs Infection

This is the most important distinction after any injection.

A steroid flare can cause pain, warmth, swelling, and stiffness, which may worry patients because these symptoms can overlap with infection. However, the overall pattern is usually different.

Feature	Steroid flare	Infection
Onset	Usually within hours of injection	May develop over days; can occasionally present earlier
Pain trajectory	Peaks early, then gradually improves	Progressively worsens or fails to settle
Fever	Absent	May be present
Redness/warmth	Mild and localised if present	Increasing, spreading, or more pronounced
Swelling	Mild to moderate and improving	Increasing or associated with severe restriction
General wellbeing	Usually well	May feel unwell, feverish, or systemically affected
Clinical concern	Low if improving	High if worsening or systemic features develop

Pain that worsens or persists beyond 72–96 hours without improvement should raise concern and should not simply be dismissed as a flare.

In joint injections, infection may present with progressive joint pain, swelling, reduced range of movement, and sometimes fever. Septic arthritis is uncommon, but it is serious and requires urgent assessment. If there is clinical concern, blood tests such as inflammatory markers may be needed, and joint aspiration may be required for cell count, Gram stain, culture, and crystal analysis.

A key point is that sterile inflammatory reactions can sometimes mimic infection. This means clinical judgement is essential. If symptoms are severe, progressive, or associated with systemic illness, the patient should be assessed urgently rather than reassured remotely.

Steroid Flare vs Tendon Injury

Tendon injury is an important consideration when steroid has been injected into or near tendons, tendon sheaths, entheses, or areas of chronic tendinopathy.

Steroid flare tends to produce a more generalised soreness around the injection site. It should gradually improve over a few days.

Tendon injury is more likely when pain is highly focal, mechanically reproducible, associated with new weakness, or linked to a clear loss of function.

Feature	Steroid flare	Tendon injury
Pain location	Diffuse around injection site	Focal along tendon or insertion
Pain quality	Soreness, aching, stiffness	Sharp, mechanical, load-related
Weakness	Usually absent	May be present
Palpable defect	Absent	May be present in partial or complete tear
Movement	Stiff and sore but improving	Specific movement becomes weak or difficult
Timeline	Improves over days	Persists or worsens with loading
Imaging	Usually not required if improving	Ultrasound or MRI may be needed

Corticosteroid exposure can affect tendon biology by reducing collagen production and impairing fibroblast activity. For this reason, post-injection advice around rest, graded loading, and avoidance of sudden overload is important, particularly after injections near tendons.

Examples where tendon or fascial complications need consideration include plantar fascia injections, Achilles or patellar tendon regions, lateral elbow tendinopathy, rotator cuff-related pain, and tendon sheath injections.

Steroid Flare vs Treatment Failure

Treatment failure is different from a flare.

A flare is an early temporary worsening after the injection. Treatment failure means the injection has not produced meaningful improvement, or the original pain returns after a short-lived benefit.

Feature	Steroid flare	Treatment failure
Timing	Immediate or within hours	Usually recognised days to weeks later
Pattern	Worse first, then improves	Little improvement, or pain returns to baseline
Pain type	Post-injection soreness plus familiar pain	Original pain pattern persists
Trajectory	Improving	Unchanged or recurrent
Meaning	Expected temporary reaction	Target may be incorrect, pathology may be advanced, or treatment effect insufficient

This distinction is especially important in tendinopathy and chronic degenerative conditions. Steroid injections can sometimes provide short-term relief but may not change the longer-term course of the underlying condition. In some tendinopathies, early improvement may be followed by recurrence of pain when activity increases or when the steroid effect wears off.

For intra-articular injections, repeated steroid exposure has also been associated in some studies with cartilage loss or progressive joint space narrowing. This does not mean that every steroid injection is harmful, but it reinforces the need for careful patient selection, appropriate spacing of injections, and realistic counselling.

Practical Clinical Assessment Pathway

When pain persists beyond the expected flare window, assessment should be structured rather than reactive. The aim is to identify whether the pattern is consistent with a settling flare or whether infection, tendon injury, neurological irritation, or treatment failure needs to be considered.

Practical Clinical Message

A steroid flare is usually an early, self-limiting reaction that gradually improves. Infection, tendon injury, and treatment failure have different patterns. The safest approach is to focus on timing, trajectory, red flags, and pain character. Improving pain is usually reassuring. Worsening pain, systemic symptoms, focal weakness, spreading redness, or major functional deterioration should prompt clinical reassessment.

Pain Flare After Spinal Injections

Pain flare after spinal injections needs a more cautious and structured approach than many peripheral joint or soft-tissue injections. This is because spinal procedures are performed close to nerve roots, the epidural space, facet joints, medial branch nerves, and other sensitive structures. A short period of soreness or temporary worsening may be expected, but clinicians must also recognise symptoms that may suggest nerve irritation, dural puncture, bleeding, infection, or another complication.

The most important principle is to distinguish expected post-procedural discomfort from pain that is progressive, neurological, systemic, or out of proportion to the procedure performed.

Epidural Steroid Injections

Epidural steroid injections may be followed by temporary local soreness, increased back or leg pain, or transient worsening of radicular symptoms. The most common delayed adverse events described include pain exacerbation, injection-site soreness, and headache. Nerve root irritation has also been reported after epidural procedures.

A typical post-epidural flare usually starts within hours, is most noticeable in the first 24–48 hours, and then gradually improves. The pain may feel like a temporary worsening of the patient’s usual back or leg symptoms.

Mechanism	Explanation
Steroid-related flare	Local inflammatory reaction to the corticosteroid preparation
Mechanical needle irritation	Temporary irritation from needle placement near sensitive spinal structures
Injectate volume effect	Temporary pressure or irritation from fluid introduced into a confined space
Nerve root irritation	Short-term increase in radicular pain due to mechanical or chemical irritation

A key distinction after epidural injection is post-dural puncture headache. This is not a steroid flare. It is classically an orthostatic headache, meaning it worsens when sitting or standing and improves when lying flat. It usually occurs within 5 days of the procedure and may be associated with neck stiffness, tinnitus, nausea, or light sensitivity.

Another serious but uncommon concern is spinal infection, such as epidural abscess. The classic triad of fever, back pain, and neurological deficit is not always present, and pain may be the main early symptom. Any new fever, progressive neurological deficit, or worsening pain beyond the expected flare window should prompt urgent assessment.

Facet Joint Injections

Facet joint injections may cause localised post-procedure soreness around the injected joint or the needle entry site. Compared with some other spinal procedures, pain flares after facet joint injections are generally described as less severe, although they can still be uncomfortable.

Transient pain at the injection site has been reported in a wide range of patients, and some may also experience radiating discomfort. Post-procedural pain exacerbation lasting up to 2 weeks has been reported in a small proportion of patients after cervical medial branch blocks.

Feature	Typical pattern
Location	Localised around the injected spinal level
Character	Aching, bruised, stiff, or sore
Timing	Begins within hours or the next day
Trajectory	Gradually improves
Duration	Often settles within days, though some soreness may last longer

Clinical assessment should focus on whether the pain remains localised and improving, or whether the patient has developed new symptoms such as radiating limb pain, weakness, numbness, fever, or progressive spinal pain.

Medial Branch Blocks

Medial branch blocks are diagnostic or prognostic injections performed around the small nerves that supply the facet joints. Because these are usually low-volume targeted injections, many patients experience only mild local soreness. However, temporary pain flare can still occur because the needle passes through skin, fascia, muscle, and periosteal tissues close to the target nerve.

After medial branch blocks, patients may notice:

• Local bruised soreness
• Temporary increase in familiar spinal pain
• Muscle stiffness or spasm around the treated area
• Short-lived tenderness at the needle entry sites
• Occasionally radiating discomfort if nearby nerves are irritated

The clinical interpretation of pain after a medial branch block requires care, because these blocks are often used diagnostically. A post-procedure flare should not be confused with a negative diagnostic result. The key question is whether the patient had meaningful pain relief during the expected local anaesthetic window before soreness returned.

For example, a patient may experience excellent short-term relief for a few hours after local anaesthetic, followed by soreness later that day or the next day. This pattern may still support the facet joint as a pain generator, despite the later flare.

Conversely, if there is no meaningful relief during the anaesthetic window and the original pain pattern remains unchanged, this may suggest that the targeted facet joint or medial branch nerves are not the dominant pain source.

Red Flags After Spinal Procedures

Most post-spinal injection discomfort is temporary and self-limiting. However, spinal procedures require clear safety-netting because complications, although uncommon, can be serious.

Urgent medical review is needed if any of the following occur:

Red flag	Why it matters
Fever or feeling systemically unwell	Possible infection
Increasing spinal pain rather than gradual improvement	Not typical of simple flare
New leg or arm weakness	Possible neurological complication
New numbness spreading or worsening	Possible nerve root or cord involvement
Loss of bladder or bowel control	Emergency neurological red flag
Saddle numbness	Possible cauda equina-type concern
Severe headache worse upright and better lying down	Possible post-dural puncture headache
Severe unrelenting night pain	Needs urgent reassessment
Increasing redness, swelling, or discharge at injection site	Possible local infection
Pain with progressive neurological symptoms	Requires urgent spinal assessment

The overall pattern is crucial. A typical flare is usually early, localised, and improving. Pain that is progressive, associated with fever, positional headache, neurological deficit, or major functional decline should not be treated as a routine flare.

Practical Clinical Message

Pain flare after spinal injections is common enough that patients should be warned about it before treatment. Epidural injections may temporarily worsen back or radicular pain, facet injections may cause localised spinal soreness, and medial branch blocks may create short-lived tenderness at the needle sites. The safest approach is to assess timing, trajectory, neurological symptoms, systemic features, and the relationship between pain relief and the expected local anaesthetic window.

Radiofrequency Ablation (RFA): Why Pain Gets Worse First

Radiofrequency ablation (RFA) is one of the most effective interventional treatments for chronic pain arising from carefully selected nerves, particularly facet-mediated spinal pain and certain peripheral pain syndromes. However, one of the most common reasons patients become concerned after treatment is that pain may temporarily worsen before improvement begins.

This short-term flare does not usually mean that the treatment has failed. In many patients, it reflects the expected tissue response to controlled thermal nerve treatment. Radiofrequency creates a targeted lesion around the pain-transmitting nerve. This reduces nociceptive signalling over time, but the treated tissues may initially become irritated and inflamed before the longer-term pain relief develops.

Understanding this sequence is essential. Unlike a local anaesthetic injection, radiofrequency treatment is not usually designed to provide instant relief. It often follows a phased recovery pattern.

How Radiofrequency Works

Conventional radiofrequency treatment uses a specialised needle electrode placed accurately beside the target nerve under image guidance. Alternating current at high frequency causes ionic agitation in the surrounding tissues, generating heat around the active tip.

When sufficient temperature is reached for an adequate duration, the target sensory nerve undergoes a controlled thermal lesion. The aim is not to destroy the whole nerve trunk, but to interrupt its ability to transmit pain signals.

This is why RFA is commonly used for:

• Medial branch nerves supplying painful facet joints
• Genicular nerves for knee pain
• Sacroiliac joint lateral branches
• Selected peripheral sensory nerves
• Other carefully chosen chronic pain generators

The therapeutic effect depends on accurate patient selection, correct targeting, lesion size, and confirmation that the target nerve is truly responsible for the pain.

The Three Recovery Phases After RFA

Recovery after radiofrequency often follows three recognisable phases.

How Long Before Patients Notice Benefit?

Pain relief after RFA is usually delayed compared with simple injections.

Some patients notice early improvement within the first 1–2 weeks once the flare settles. However, many patients require 2 to 6 weeks before clear benefit becomes apparent, and some continue improving over 8 to 12 weeks.

Process	Why benefit is delayed
Post-procedure inflammation	Early soreness can temporarily mask benefit
Neural conduction interruption evolves over time	Pain signalling reduction is not always immediate

Patients should therefore be counselled that judging success in the first few days is often misleading.

7.4 Typical Duration of Post-RFA Flare

Most post-RFA flare reactions are temporary.

Time after procedure	Typical experience
First 72 hours	Soreness, bruised pain, stiffness
Days 3–14	Local flare may peak or fluctuate
Weeks 2–4	Gradual settling begins
Beyond 4 weeks	Persistent severe pain needs reassessment

Some mild residual soreness may last longer, especially in previously sensitised patients or in weight-bearing regions.

Persistent severe pain, new neurological symptoms, spreading pain, fever, or progressive functional decline should not be assumed to be a normal flare.

How Long Does Pain Relief Usually Last?

When RFA is successful, pain relief often lasts substantially longer than local anaesthetic or steroid injections because the treated nerve requires time to regenerate.

Target area	Common duration range
Lumbar medial branch RFA	6–18 months
Cervical medial branch RFA	6–15 months
Genicular nerve RFA	6–12 months
Sacroiliac lateral branch RFA	Variable, often 6–12 months
Peripheral nerve targets	Depends on condition and target

Pain may gradually return as the nerve regenerates or as the underlying condition progresses. Many patients who responded well initially can be considered for repeat treatment when symptoms recur.

Practical Clinical Message

Radiofrequency often gets worse before it gets better because it creates a controlled therapeutic lesion rather than instant numbing. Early flare is common, improvement is often delayed, and success should usually be judged over weeks rather than days. Careful counselling before treatment greatly improves patient confidence and reduces anxiety during the normal recovery phase.

Post-RFA Pain Flare vs Post-Neurotomy Neuritis (PNN)

Pain after radiofrequency ablation is not all the same. A patient may experience ordinary post-procedural soreness from cannula placement and thermal tissue irritation, or they may develop a more neuropathic pain pattern known as post-neurotomy neuritis (PNN).

PNN is most commonly discussed after radiofrequency procedures involving the lumbar medial branch nerves, cervical medial branch nerves, and especially the third occipital nerve (TON) during C2–3 radiofrequency denervation. It may also be relevant after sacroiliac lateral branch radiofrequency and selected peripheral sensory nerve procedures.

In lumbar medial branch radiofrequency, the intended target is the medial branch supplying the painful facet joint. However, post-neurotomy neuritic symptoms are often thought to arise from unintended involvement of nearby lateral branches or lateral cutaneous branches of the dorsal ramus rather than the medial branch itself. These collateral sensory branches supply superficial tissues and skin, which explains why some patients develop burning skin pain, patchy numbness, hypersensitivity, or altered sensation over the lower back or flank.

In cervical procedures, the third occipital nerve is the classic recognised culprit because it has a cutaneous sensory distribution. Irritation after C2–3 denervation may produce upper neck or occipital scalp burning, numbness, itching, or dysaesthesia.

These symptoms are different from the deeper aching, bruised discomfort of a routine post-procedure flare. Distinguishing the two is clinically important because they have different mechanisms, different symptom patterns, and may respond to different treatment approaches.

Why They Are Different Conditions

A standard post-RFA pain flare is mainly an inflammatory and nociceptive reaction. It is caused by the procedure itself: cannula placement, local soft-tissue irritation, thermal lesioning, and the normal inflammatory response after controlled tissue injury.

Post-neurotomy neuritis is different. It is more specifically related to nerve irritation or neuritic sensitivity after ablation. The pain is usually neuropathic in character and may involve burning, dysaesthesia, hypersensitivity, numbness, itching, or altered sensation in the region supplied by affected sensory branches.

The distinction can be difficult because both can occur after the same procedure and both may begin during the first few days or weeks. A patient may also have a mixture of inflammatory soreness and neuritic symptoms.

Clinical Features of Standard Flare

A standard post-RFA flare is common and usually expected. It often reflects local tissue trauma from the cannula and heat-related irritation around the treatment site.

Typical features include:

• Deep aching pain
• Bruised or sore feeling
• Local tenderness at the treatment site
• Muscle stiffness or guarding
• Temporary increase in familiar pain
• Pain that is worst early and then gradually improves

This type of pain is usually more somatic than neuropathic. It tends to feel like post-procedure soreness rather than nerve pain. The expected course is gradual improvement over days to a few weeks.

Clinical Features of Post-Neurotomy Neuritis

Post-neurotomy neuritis is a more neuropathic pain state. It may occur when sensory nerve branches are irritated, transected, or become sensitised after thermal lesioning.

Typical features include:

• Burning pain
• Shooting, electric, or lancinating discomfort
• Dysaesthesia or unpleasant altered sensation
• Tingling, prickling, or pins and needles
• Cutaneous hypersensitivity or allodynia
• Numbness in the treated region
• Itching or crawling sensations
• Pain that feels different from the original mechanical pain

The third occipital nerve is particularly important because neuritis after C2–3 denervation may produce burning, numbness, dysaesthesia, itching, or hypersensitivity in the upper neck, occipital scalp, or related cutaneous distribution.

After lumbar medial branch radiofrequency, neuritic symptoms may be felt more superficially over the paraspinal region, lower back, or flank if nearby lateral branches or lateral cutaneous branches of the dorsal ramus are affected. Patients may describe sensitivity to clothing, patchy numbness, raw skin discomfort, or burning that feels different from the original facet-mediated pain.

Unlike standard flare, PNN may last longer and may be more troublesome because neuropathic pain often responds less reliably to simple anti-inflammatory strategies.

Comparison Table

Feature	Standard Post-RFA Pain Flare	Post-Neurotomy Neuritis (PNN)
Main mechanism	Cannula trauma, thermal tissue irritation, local inflammation	Nerve irritation, sensory branch involvement, neuritic sensitisation
Commonly involved nerves	Treatment-site soft tissues around the target nerve	Lumbar medial branch region, cervical medial branch region, third occipital nerve, sacroiliac lateral branches, and nearby lateral or lateral cutaneous branches of the dorsal ramus
Pain type	Nociceptive / inflammatory	Neuropathic
Pain quality	Deep, aching, bruised, sore	Burning, electric, shooting, dysaesthetic, raw skin sensation
Onset	Usually immediate or within hours to days	Often days to weeks after procedure
Location	Around the treatment site	Treatment site or cutaneous sensory distribution, such as occipital scalp after TON treatment or superficial lower back/flank after lumbar RFA
Associated symptoms	Local tenderness, stiffness, muscle guarding	Numbness, tingling, allodynia, hypersensitivity, itching, crawling sensation
Duration	Usually days to a few weeks	May last weeks to months in some patients
Expected trajectory	Gradual improvement	Variable; may persist, fluctuate, or resolve slowly
Response to NSAIDs	Often helpful if appropriate	Often less reliable
Clinical implication	Usually expected recovery	Consider neuropathic pain assessment and management if persistent or severe

When to Suspect Neuropathic Complications

Neuropathic complications should be considered when the post-RFA pain is not simply sore or bruised, but has a distinctly nerve-like quality.

PNN should be suspected when patients describe:

• Burning pain rather than aching pain
• Electric shocks or shooting pain
• Painful sensitivity to light touch or clothing contact
• New numbness or altered skin sensation
• Dysaesthesia in a cutaneous distribution
• Itching, crawling, or prickling sensations
• Patchy superficial hypersensitivity over the treated region
• Symptoms persisting beyond the expected inflammatory flare window
• Pain that feels clearly different from the original pain

The presence of neuropathic symptoms does not automatically mean a serious complication has occurred. Many cases are temporary. However, persistent or severe neuritic symptoms may require reassessment and a different management approach.

Possible management considerations include:

• Careful clinical review
• Documentation of neurological findings
• Screening for red flags such as new weakness or progressive sensory loss
• Neuropathic pain medication where appropriate
• Topical agents in selected cases
• Local treatment at the ablation site in selected patients
• Reassurance and monitoring when symptoms are mild and improving

Practical Clinical Message

A standard post-RFA flare usually feels sore, bruised, deep, and inflammatory. Post-neurotomy neuritis feels more burning, electric, hypersensitive, itchy, numb, or dysaesthetic. In lumbar medial branch radiofrequency, neuritic symptoms are often thought to arise from unintended involvement of nearby lateral branches or lateral cutaneous branches of the dorsal ramus rather than the medial branch target itself. In cervical radiofrequency, the third occipital nerve is the classic recognised culprit after C2–3 denervation. The distinction is not always clear in the first few days because both can overlap, but the quality of pain, sensory symptoms, duration, and trajectory help guide clinical interpretation.